Press release
11.06.2021 To the attention of interested persons Vaxzevria: EMA advises against use in people with history of capillary leak syndrome […]
Press release
08.06.2021 To the attention of interested persons EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 […]
Press release
07.06.2021 To the attention of interested persons EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia […]
Important notification
07.06.2021 To the attention of Romanian manufacturers of medical devices/authorised representatives European Medical Device Nomenclature (EMDN) We inform you that […]
Press release
01.06.2021 To the attention of interested persons Additional manufacturing capacity for BioNTech/Pfizer’s COVID-19 vaccine. download document …
Press release
28.05.2021 To the attention of interested persons First COVID-19 vaccine approved for children aged 12 to 15 in EU. download […]
Press release
27.05.2021 To the attention of interested persons Insufficient data on use of inhaled corticosteroids to treat COVID-19 download document …
Press release
21.05.2021 To the attention of interested persons EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19. download document […]
Press release
21.05.2021 To the attention of interested persons Vaxzevria: further advice on blood clots and low blood platelets. download document …
Important notification
18.05.2021 To the attention of stakeholders The unique identification system of medical devices (UDI), in accordance with Regulations (EU) 2017/745 […]